Reviewed: A Delicate Truth by John le Carré

Secrets and lies.

A Delicate Truth
John le Carré
Viking, 336pp, £18.99

Behind the conspiracy that drives John le Carré’s new novel is an American private defence company that calls itself “Ethical Outcomes”. It might more accurately have called itself “Unethical Incomes”. Like all of his novels, A Delicate Truth asks how to create ethical outcomes in an increasingly venal society. In the cold war thrillers that established his reputation, le Carré followed the effects of the conflict between the ideologies of east and west, “communism” v“freedom”. Over the past decade or so, his books have increasingly focused on the moral vacuum that has emerged from the hollow triumph of capitalism, as we all discover that there is nothing free about a world in which anything is potentially for sale – on the contrary, it is proving very costly indeed.

If 2001’s The Constant Gardener was le Carré’s attack on Big Pharma, A Delicate Truth is an attack on what he calls “Big Greed” – the transformation of a market economy into a market society. Big Greed is ruining le Carré’s Britain, which is becoming less great by the day: there are no George Smileys left in this atomised society. Instead, a toxic individualism holds sway, which can only be answered by the increasingly rare consciences of honest men fighting their way through a dishonourable world.

The novel opens with American mercenaries in 2008 engaged in a bit of extraordinary rendition in Gibraltar, using a British diplomat named Kit Probyn as a “fig leaf” to cover their illegal operation on foreign soil. Probyn has been ordered by the minister of defence, one Fergus Quinn, to come to the aid of Queen and country, believing that the objective of “Operation Wildlife” is counter - terrorism. Eventually, Probyn learns that he was unwitting in more ways than one: told that the top-secret operation had been an unqualified success, he was shipped off to a plum post in the Caribbean and knighted, when, in reality, the operation – unethical on the face of it –was far more immoral than he knew and a fiasco to boot.

Meanwhile, Quinn’s secretary, Toby Bell, who has refused to countenance what he suspects is his minister’s hand in the nation’s till, becomes increasingly suspicious of Quinn’s dealings with the mysterious J Crispin. The name is presumably a deeply ironic reference to Henry V’s St Crispin’s Day speech, for this Crispin is busily selling arms, honour and country to the highest bidder. (The literary allusions don’t end there: Quinn calls Toby “old sport” – the italics are le Carré’s and irritating – and, two pages later, Toby wonders whether the J Crispin of whom he has heard might be named “Jay like Jay Gatsby”. Whether this is an allusion to Crispin’s criminal allegiances or his fraudulence or a wry undermining of the way that people like him are destroying American and British dreams of equality and meritocracy is impossible to say, because le Carré abandons the comparison, never to return to it.)

Toby acquires incriminating evidence about Operation Wildlife and joins forces with Probyn to expose the nefarious plot of Crispin and Quinn. The problem is that no one in their government wants it exposed. Faced with a secret state relying on plausible deniability and the subcontracting of its dirty work, Toby and Kit must search for a way to hold power accountable.

At the heart of the story is a Hitchcockian McGuffin: Toby has a recording of a secret meeting, in the comically low-tech form of reel-to-reel tapes, relics of the cold war era that no one has remembered to remove from ministerial offices. As the questions mount, so does the suspense: what really happened on the night of Operation Wildlife? What are Crispin’s real plans and who does he work for? What was the operation’s objective, behind the cover-up, and how did it go so spectacularly awry? The problem with A Delicate Truth is that the McGuffin is just that – a device so uninteresting that le Carré doesn’t even bother to answer all of these questions. He has planted the device purely for the purposes of denouncing the duplicity and hyp - ocrisy of the new secret state.

At his best, le Carré parses the workings of conflicted loyalties, the balancing of one value against another, of moral idealism against political realism. Lately, his novels have traded less in moral ambiguity and more in the certainties of heroes and villains. The book vibrates with le Carré’s patent indignation at the sense that our politicians are betraying all of us and the values they are meant to uphold. Instead of asking difficult questions about whether unethical means can justify ethical ends, however, A Delicate Truth pits the ethical against the unethical, good guys against bad, the moral against the amoral, honest British soldiers against dishonest American mercenaries.

At almost the dead centre of the novel, Kit Probyn, who has retired with his wife to a picturesque village in Cornwall, attends the local “annual fayre”, over which he has been asked to preside as the lord of misrule. “It’s here and now, Kit thinks, as the elation rises in him,” Le Carré writes.

The jostling crowds, the palominos cavorting in the meadows, the sheep safely grazing on the hillside, even the new bungalows that deface the lower slopes of Bailey’s Hill: if this isn’t the land they have loved and served for so long, where is? And all right, it’s Merrie bloody England, it’s Laura bloody Ashley, it’s ale and pasties and yo-ho for Cornwall, and tomorrow morning all these nice, sweet people will be back at each other’s throats, screwing each other’s wives and doing all the stuff the rest of the world does. But right now it’s their National Day, and who’s an ex-diplomat of all people to
complain if the wrapping is prettier than what’s inside?

Yet his recognition that this is sentimental nonsense does not make it less sentimental or less nonsensical. Le Carré once told an interviewer that his style developed from his training as a young intelligence officer writing reports: “We went for a bald style . . . profound suspicion of adjectives, and making the verb do the work.” A Delicate Truth continues to follow this stylistic principle but he should be more suspicious of this adjectival scene. It is disconcerting, to say the least, to read a writer of le Carré’s acuity defending the pretty wrapper of heritage tourism and superficial patriotism. This scene undermines everything that the novel ought to be about: defending the heart of the nation, not its selfdeceiving trappings.

As if to compensate for the degradation of the world he portrays, le Carré has responded with fictions that are increasingly consoling and heroes who are rewarded with upright women who stiffen their moral backbones. These women may be more admirable than the serially unfaithful Ann Smiley of earlier books but they are no less one-dimensional. If they are not quite cardboard characters, there is certainly no George Smiley here, either. And the plot proves to be as under - developed as the characters, the conspiracy so gestural, that it is hard to remember that the author is the man who gave us the intricate, internecine plots of Smiley’s world.

In the end, the question of what happens to the whistle-blower is at the heart of the story and the best thing about this book is its final paragraph, in which le Carré gives his deeply sinister answer to that question. That paragraph alone makes A Delicate Truth worth reading, not only for the obvious pleasures to be offered by a master of suspense but for the brutal truth he forces us to confront at the story’s end.

Sarah Churchwell’s “Careless People: Murder, Mayhem and the Invention of the Great Gatsby” will be published in June by Little, Brown

John le Carré at home in Cornwall in 2010. Photograph: Paul Calver

This article first appeared in the 29 April 2013 issue of the New Statesman, What makes us human?

Getty
Show Hide image

The best defence against Alzheimer’s

Spoiler: the best way to avoid Alzheimer's is to stay young.

At the recent meeting of the European Academy of Neurology in Copenhagen, doctors were signing up to attend a workshop teaching non-specialists to test for cognitive decline in their patients. How do you tell the difference between a scatterbrain and a case of early dementia?

It’s a question that is increasingly urgent. Last year, 47.5 million people were living with dementia. That will have risen to 75.6 million by 2030 and will reach 140 million in 2050. The World Health Organisation has declared that dementia should be regarded as a global public health priority. But what can we do about it?

The primary cause of dementia, accounting for roughly 70 per cent of cases, is Alzheimer’s disease. It’s all very well to put a name to it, but we don’t have a clear understanding of the mechanisms that cause it – or medicines to battle it. Alzheimer’s drugs have a high rate of failure. In the decade to 2012, 99.6 per cent of newly developed drugs failed to make it past clinical trials. There is no cure for Alzheimer’s and none on the horizon, either.

There was, however, a small breakthrough last month. A study published in the journal Science Translational Medicine suggests that Alzheimer’s could be a result of fighting infections from other diseases that would, if left unchecked, ravage the brain. The hard lumps of sticky plaque in the brain that characterise the onset of Alzheimer’s seem to be the result of the immune system attempting to isolate and neutralise microbes and other pathogens that have made their way into the brain. The plaques catch pathogens, preventing infection from taking hold. Unfortunately, it’s a case of damned if you do, damned if you don’t: the plaques also trigger inflammation that leads to the death of brain cells.

This observation mirrors another catch-22 with Alzheimer’s. Some researchers have suggested that the drug failures might be averted by getting candidate treatments to the disease earlier, before symptoms appear. Put simply, the drugs may stand a better chance of success when trying to counter the first stages of damage to the brain. The problem is: how do you get that early diagnosis?

There are various genetic indicators for a heightened predisposition to developing Alzheimer’s. A gene called apolipoprotein E, for instance, comes in three variants: one kind seems to reduce the risk of Alzheimer’s while another increases it. Other genes – variously associated with the body’s uptake of cholesterol, its propensity to engender inflammation and the efficiency of communication between neurons – also have a role to play in raising or lowering the chances of onset.

However, the interplay between genetic factors, environmental factors and what appears to be pure luck makes foreknowledge of whether Alzheimer’s will strike any individual impossible. It’s no wonder that the US National Institutes of Health does not generally recommend genetic testing as a worthwhile route for anyone wanting to know their future. After all, a result that indicates you are more likely than the average person to develop dementia is, in many ways, little more than a heavy psychological burden, to be borne until the symptoms start to appear – a scenario that keeps you stressed (a grave health risk) even if onset never happens. If the drugs don’t work yet, why would anyone sign up to be tested?

In the absence of a reliable test or cure, the best advice seems to be to delay ageing as much as possible, particularly where cardiovascular health is concerned. It’s an observation that fits with last month’s breakthrough. The plaque-provoking pathogens reach the brain through the weakening of the blood-brain barrier, a wall of cells that wraps around blood vessels and prevents foreign bodies from passing into the brain’s circulatory system. This weakening happens with age, suggesting that action to delay the degradation of the cardiovascular system will also delay the onset of Alzheimer’s disease.

Here, at least, we have some good news: the rate of appearance of dementia cases seems to be in decline. This may be a spin-off of our attempts to cut deaths from heart disease. It seems that as we take control of blood pressure and cholesterol levels, making significant improvements to our heart and circulatory function, we are unwittingly improving our cerebral health, too – almost certainly because the brain requires good blood flow to operate well.

The surest way to avoid Alzheimer’s, then, is simple to state and impossible to achieve. All you have to do is stay young. 

Michael Brooks holds a PhD in quantum physics. He writes a weekly science column for the New Statesman, and his most recent book is At the Edge of Uncertainty: 11 Discoveries Taking Science by Surprise.

This article first appeared in the 23 June 2016 issue of the New Statesman, Divided Britain